theragenomics: targeted therapies

thasso provides here an ever growing table of targeted therapies, meaning a gene, an allelic variant there of, or a mutation is the at the base of the decision if a therapy may successfully be applied to a patient or a group of patients who carry the according genetic outfit. At present, this concept is mostly, but not exclusively,  applied in cancer treatment. For more information, particularly in oncology  you may also consult My Cancer Genome.


[table id=10 /]


(* ) More than one drug label may be available with a given active ingredient or commercial drug name

(**) Bexxar is no longer on the market

Table updated November 10, 2016.